Check Out Hims & Hers Health Inc (HIMS)’s Trade Data Rather Than the Analysts’ Views

With 72.48 million shares changed hands, the volume of the stock remained heavier than its average volume of 30.58 million shares. The 52-week range on HIMS shows that it touched its highest point at $72.98 and its lowest point at $11.20 during that stretch. It currently has a 1-year price target of $45.07. Beta for the stock currently stands at 1.88.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HIMS was up-trending over the past week, with a rise of 47.05%, but this was up by 49.62% over a month. Three-month performance surged to 7.58% while six-month performance rose 119.96%. The stock gained 234.77% in the past year, while it has gained 73.20% so far this year. A look at the trailing 12-month EPS for HIMS yields 0.53 with Next year EPS estimates of 0.90. For the next quarter, that number is 0.15. This implies an EPS growth rate of 14.80% for this year and 47.64% for next year. EPS is expected to grow by 33.63% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 17.22%.

Float and Shares Shorts:

At present, 212.46 million HIMS shares are outstanding with a float of 183.36 million shares on hand for trading.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. The EBITDA in the recently reported quarter was $24657000.0 and diluted EPS was $nan.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HIMS since 13 analysts follow the stock currently. There are 7 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 5 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.57903 being high and $0.50051 being low. For HIMS, this leads to a yearly average estimate of $0.53977.